Baotou Dongbao Bio-Tech Co.,Ltd (SHE:300239)
China flag China · Delayed Price · Currency is CNY
4.810
-0.030 (-0.62%)
Oct 23, 2026, 3:04 PM CST

SHE:300239 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
833.4743.59850.21970.41937.89609.82
Other Revenue
1.721.7234.724.15.512.34
835.12745.31884.93974.51943.4612.17
Revenue Growth
6.44%-15.78%-9.19%3.30%54.11%36.39%
Cost of Revenue
667.17587.36687.88728.53712.28515.98
Gross Profit
167.94157.95197.06245.98231.1296.19
Selling, General & Admin
70.8269.2167.9669.7567.8140.1
Research & Development
26.725.4827.3626.125.8312.98
Other Operating Expenses
14.298.64.9212.5812.529.23
Operating Expenses
113.03104.1499.82110.21106.4762.34
Operating Income
54.9253.8197.23135.77124.6533.85
Interest Expense
-0.86-4.01-2.56-5.14-7.63-4.78
Interest & Investment Income
0.82.787.116.374.842.88
Currency Exchange Gain (Loss)
0.120.121.030.260.7-0.03
Other Non Operating Income (Expenses)
-3.08-0.29-0.18-0.17-0.211.44
EBT Excluding Unusual Items
51.952.4102.63137.08122.3533.37
Gain (Loss) on Sale of Investments
-1.91-2.86-3.74-4.33-1.91-2.53
Gain (Loss) on Sale of Assets
0.01-0.09-0.280.080.140.09
Asset Writedown
0.25-0.27-0.88-0.86-0.42-0.6
Other Unusual Items
15.9312.197.7912.4711.2511.21
Pretax Income
66.7361.92105.63144.49131.6541.54
Income Tax Expense
5.97.5814.3717.1216.215.72
Earnings From Continuing Operations
60.8354.3491.26127.37115.4435.82
Minority Interest in Earnings
-00-5.28-7.49-60.66
Net Income
60.8354.3485.98119.89109.4436.48
Net Income to Common
60.8354.3485.98119.89109.4436.48
Net Income Growth
-10.75%-36.80%-28.28%9.55%199.96%97.74%
Shares Outstanding (Basic)
591586594593593564
Shares Outstanding (Diluted)
612626647612593564
Shares Change
-3.90%-3.24%5.72%3.12%5.25%7.89%
EPS (Basic)
0.100.090.140.200.180.06
EPS (Diluted)
0.100.090.130.200.180.06
EPS Growth
-7.13%-34.69%-32.16%6.24%185.01%83.29%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-69.2226.65-8.0467.1586.760.15
Free Cash Flow Per Share
-0.110.04-0.010.110.15-
Dividend Per Share
0.0120.0120.0250.0220.0260.006
Dividend Growth
-52.00%-52.00%13.64%-15.38%333.33%-
Gross Margin
20.11%21.19%22.27%25.24%24.50%15.71%
Operating Margin
6.58%7.22%10.99%13.93%13.21%5.53%
Profit Margin
7.28%7.29%9.72%12.30%11.60%5.96%
Free Cash Flow Margin
-8.29%3.58%-0.91%6.89%9.20%0.02%
EBITDA
160.12150.97183.67217.73210.1689.17
EBITDA Margin
19.17%20.26%20.76%22.34%22.28%14.57%
D&A For EBITDA
105.297.1686.4481.9685.5255.32
EBIT
54.9253.8197.23135.77124.6533.85
EBIT Margin
6.58%7.22%10.99%13.93%13.21%5.53%
Effective Tax Rate
8.85%12.25%13.60%11.85%12.31%13.76%
Revenue as Reported
212.51745.31884.93974.51943.4612.17
Advertising Expenses
-0.850.571.121.080.81